Get started
Author

Pauline P. Chen

Observed names: Pauline Chen, Pauline P Chen, Pauline Ping Chen, Ping (Pauline) Chen, Ping Chen
ORCID: 0000-0002-4730-3370
Observed ORCID: 0000-0002-4730-3370
OpenAlex ID: A5091020166
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients
2021 · Pauline P. Chen, Alma-Martina Cepika, et al. · Science Translational Medicine · 71
Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells
2020 · Brandon Cieniewicz, Molly Javier Uyeda, et al. · Haematologica · 23
PDF
BHLHE40 Regulates IL-10 and IFN-γ Production in T Cells but Does Not Interfere With Human Type 1 Regulatory T Cell Differentiation
2021 · Molly Javier Uyeda, Robert A. Freeborn, et al. · Frontiers in Immunology · 21
PDF
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell killing of AML
2024 · Ece Canan Sayitoglu, Bogdan A. Luca, et al. · Leukemia · 20
APVO210: A Bispecific Anti-CD86-IL-10 Fusion Protein (ADAPTIR™) to Induce Antigen-Specific T Regulatory Type 1 Cells
2018 · Laurence Pellerin, Ping Chen, et al. · Frontiers in Immunology · 20
PDF
Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy
2021 · Jeffrey Mao-Hwa Liu, Ping Chen, et al. · Cytotherapy · 12
PDF
Epigenetic landscape, key transcriptional regulators, and in vivo identification of human Tr1 cells
2026 · Alma-Martina Cepika, Laura Amaya, et al. · Science Advances · 3
T-allo10 Immunotherapy Results in Enhanced Early Immune Reconstitution and Reduced GvHD with Excellent Clinical Outcomes Post Αβ-Depleted HSCT in Pediatric and Young Adult Hematologic Malignancy Patients
2024 · Alice Bertaina, Rosa Bacchetta, et al. · Blood · 2
PDF
Enhanced Immune Reconstitution and Reduced GvHD Risk with T-allo10 Infusion Post Aβdepleted-HSCT in Pediatric and Young Adult Patients with Hematologic Malignancies
2024 · Alice Bertaina, Rosa Bacchetta, et al. · Transplantation and Cellular Therapy · 2
T-allo10 Infusion after αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Improved Immune Reconstitution in the Absence of Severe GvHD
2023 · Alice Bertaina, Rosa Bacchetta, et al. · Transplantation and Cellular Therapy · 2
Regulatory Type 1 T Cell Infusion in Mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies
2020 · Rajni Agarwal, Rosa Bacchetta, et al. · Transplantation and Cellular Therapy · 2
Regulatory Type 1 T Cell Infusion in Mismatched Related or Unrelated Hematopoietic Stem Cell Transplantation (HSCT) for Hematologic Malignancies
2019 · Rajni Agarwal, Rosa Bacchetta, et al. · Transplantation and Cellular Therapy · 1
T-allo10 Cell Addback Post-Αβdepleted-HSCT Drives Lasting Leukemia-Free Survival with Distinct Immune Regulation Biomarkers
2026 · Alice Bertaina, Rosa Bacchetta, et al. · Transplantation and Cellular Therapy
Phase 1/1b Study of T-allo10 Infusion after HLA-Partially Matched αβ depleted-HSCT in Children and Young Adults with Hematologic Malignancies: Preliminary Results
2022 · Alice Bertaina, Rosa Bacchetta, et al. · Transplantation and Cellular Therapy
146 Alloantigen-specific Tr1 cells designed to prevent GvHD have a distinct molecular identity and suppress through CTLA-4 and PD-1
2020 · Alma-Martina Cepika, Pauline P Chen, et al. · Journal for ImmunoTherapy of Cancer
Engineered Type-1 Regulatory T Cells as Cellular Therapy for Treatment of Immune Mediated Diseases
2020 · Jeffrey M Liu, Pauline Chen, et al. · The Journal of Immunology
Works count: 16
Citation count: 179
H-index: 6
I10-index: 6
Year
Topic
Type